Siolta Therapeutics
Provider of microbiome therapeutics for treating multiple diseases. The company is focusing on the development of targeted human microbiome therapeutics for the prevention and treatment of chronic inflammatory diseases, starting with allergic diseases. The company's flagship product is STMC-103H for treating atopic dermatitis, food allergy, and allergic asthma. Founded in 2016, headquartered in San Francisco, United…
Funding snapshot
About
Provider of microbiome therapeutics for treating multiple diseases. The company is focusing on the development of targeted human microbiome therapeutics for the prevention and treatment of chronic inflammatory diseases, starting with allergic diseases. The company's flagship product is STMC-103H for treating atopic dermatitis, food allergy, and allergic asthma. Founded in 2016, headquartered in San Francisco, United States. The company has raised $42.0M in funding at the series c stage. The company operates in the Genomics sector with additional focus on Microbiome Therapeutics and Immunology. Its business model centers on Endocrine disorders. Founded in 2016, headquartered in San Francisco, United States. The company has raised $42.0M at the Series C stage. Backed by investors including SymBiosis, Khosla Ventures, Seventure Partners, Global Brain, TimeVentures and others.
Business model
Metabolic Diseases > Drugs > Endocrine disorders,
Dermatology > Drugs > Diversified,
Immunology > Drugs > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Microbial Testing > Microbiomics
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.